Idaho woman files lawsuit over Ortho Evra patch

Key points
- A woman in Idaho who said she developed a blood clot disorder after using the birth control patch Ortho Evra - made by Ortho-McNeil, a subsidiary of Johnson & Johnson - has filed a lawsuit in federal court against the companies, the AP/Houston Chronicle reports.
- Katy McKellips Braman said that she began using the patch in 2004 at age 17 and that about one month later, she was diagnosed with deep vein thrombosis - a sometimes fatal condition characterized by leg vein blood clots that can break off and spread to the lungs - the AP/Chronicle reports.
- In the lawsuit, Braman says that the patch caused her disorder and that she now must take daily anticlotting medications that prevent her from ever taking medications containing estrogen, such as birth-control pills or treatments for menopause and hormonal imbalances.
- The lawsuit also claims that the companies failed to adequately test the patch and that they deceived customers by saying the patch's risks were equivalent to those associated with other contraceptives.
A woman in Idaho who said she developed a blood clot disorder after using the birth control patch Ortho Evra - made by Ortho-McNeil, a subsidiary of Johnson & Johnson - has filed a lawsuit in federal court against the companies, the AP/Houston Chronicle reports.
Katy McKellips Braman said that she began using the patch in 2004 at age 17 and that about one month later, she was diagnosed with deep vein thrombosis - a sometimes fatal condition characterized by leg vein blood clots that can break off and spread to the lungs - the AP/Chronicle reports.
In the lawsuit, Braman says that the patch caused her disorder and that she now must take daily anticlotting medications that prevent her from ever taking medications containing estrogen, such as birth-control pills or treatments for menopause and hormonal imbalances.
The lawsuit also claims that the companies failed to adequately test the patch and that they deceived customers by saying the patch's risks were equivalent to those associated with other contraceptives.
Braman is asking that the court require the companies to pay compensatory damages and costs of future medical treatments (Boone, AP/Houston Chronicle, 10/17).
FDA in September announced it had updated Ortho Evra's warning label to include information from two conflicting studies on increased risk of blood clots among patch users (Kaiser Daily Women's Health Policy Report, 9/21).
Ortho-McNeil spokesperson Julie Keenan said the company could not comment on the pending lawsuit, and officials with Johnson & Johnson did not return calls for comment.
According to company officials, hundreds of lawsuits over the patch have been filed nationwide (AP/Houston Chronicle, 10/17).
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Women's Health →
NewsHysterectomy can be safely combined with cosmetic surgery for 'hanging abdomen'
For women undergoing hysterectomy, removal of "hanging" abdominal fat and skin--a cosmetic procedure called panniculectomy - can be performed at the same surgery without increasing the risk of complications, reports a…
3 September 2015
NewsWomen undergoing fertility treatment can succeed with fewer hormones
Since the early days of fertility treatment, women undergoing IVF treatment have had to place a hormonal gel in their vagina on a daily basis for at least 14 days after embryo transfer. The hormone is necessary to…
26 August 2015
NewsData mining DNA for polycystic ovary syndrome genes
Polycystic ovary syndrome (PCOS) has been passed down in many families for generations - causing reproductive and metabolic health problems for millions of women around the world. Yet, its cause remains unknown despite…





